尿中微量アルブミン簡易測定法(ED002)の検討
玲子 小田桐, Hanae Abe, 千恵子 高橋 et al. · Institutional Repositories DataBase (IRDB) · 1989
All diabetics should be screened to identify patients at risk of developing clinical nephropathy. EDOO2 test is a rapid,10w priced, two minutes test easily performed in the clinic, for the detection of microalbuminuria. The priniciple used is that of Latex agglutination inhibition. A urine sample is mixed on a test card with a solution containing human antibodies to albumin. If albumin is present in the urine, it will react with the antibodies in solution, forming an antigen-antibody complex. We studied fresh, first morning urine sample from 203 diabetic patients. Urinary albumin concentration was measured in all samples by Radioimmunoassay(RIA). Thirty one cases with albumin concentration>29 mg/1 read positive(i.e. agglutination was inhibited)with the EDOO2 test. In these, albumin concentration ranged between 29-120 mg/1. The remaining 172 cases, with albumin concentration ranging between O.5 and 28 mg/1 read negative. A strong correlation exists between microalbuminuria at the EDOO2 test and RIA(97.2%). There was significantly higher incidence of hypertension, severe retinopathy and longer duration in relation to urinary albumin among patients with positive than negative at the EDOO2 test. These results show that EDOO2 test may prove useful in the outpatients setting. 緒 言 尿中アルブミンの微量測定は,糖尿病性腎症の 早期モニターとして有用視されている. 近年Keenら1)により開発された,ラジオアイソ トープを用いた尿中微量アルブミンの測定は通常 の試験紙法により,尿蛋白陰性である糖尿病患者 (IDDM)の尿中アルブミンは健常者に比較して, 有意に高値であり,このアルブミン排泄量の増加 しているものでは,糖尿病性腎症へ移行する頻度 が高く,生命予後の判定にも用いられている2)3). 測定方法はRIA法・免疫比濁法(TIA)は非常に 高感度で2.5μg/1となっているものが使用されて いる.これらの方法は,正確な値が得られるもの の,
Cited by 0 works. Open-access PDF